DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment First published 22/04/2024 Last updated 23/06/2025 EU PAS number:EUPAS1000000112 Study Ongoing